Insight Molecular Diagnostics Inc. (IMDX) Shareholders’ equity 2020–2025
Insight Molecular Diagnostics Inc. (IMDX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$31.5MFY2025 · since FY2020: $33.5M → -$31.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.5M | -156.3% |
| FY2024 | -$12.3M | -160.0% |
| FY2023 | $20.5M | -40.3% |
| FY2022 | $34.3M | -47.4% |
| FY2021 | $65.2M | +94.8% |
| FY2020 | $33.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice